Cargando…
Lopinavir/ritonavir/tocilizumab: Myositis, Staphylococcus epidermidis bacteraemia, hepatitis and ventilator-associated pneumonia following off-label use: 3 case reports
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7498990/ http://dx.doi.org/10.1007/s40278-020-83543-y |
Ejemplares similares
-
Lopinavir/ritonavir/tocilizumab: Hypertriglyceridaemia following off-label use: 2 case reports
Publicado: (2020) -
Hydroxychloroquine/lopinavir/ritonavir/tocilizumab: Lack of efficacy following off label use: case report
Publicado: (2022) -
Lopinavir/ritonavir: Hepatic cytolysis following off-label use: case report
Publicado: (2021) -
Lopinavir/ritonavir/sirolimus interaction: Hepatitis following an off-label use: case report
Publicado: (2022) -
Lopinavir/ritonavir: Hyperlipidaemia following off-label use: case report
Publicado: (2020)